首页> 外文OA文献 >PDB50 The Cost-Effectiveness Evaluation of Canagliflozin Versus Dapagliflozin In Patients with type 2 Diabetes Mellitus Inadequately Controlled On Metformin Monotherapy In Spain

【2h】

PDB50 The Cost-Effectiveness Evaluation of Canagliflozin Versus Dapagliflozin In Patients with type 2 Diabetes Mellitus Inadequately Controlled On Metformin Monotherapy In Spain

机译：PDB50西班牙二甲双胍单药治疗不能充分控制2型糖尿病患者中Canagliflozin与Dapagliflozin的成本-效果评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nielsen A.T.; Pitcher A.; Lovato E; Schubert A; Hemels M; Neslusan C; González B;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial [J] . Jabbour Serge A., Frias Juan P., Hardy Elise, Diabetes care . 2018,第10期

机译：Exenatide每周一次的安全性和疗效加上Dapagliflozin每日一度，并且单独服用exenatide或Dapagliflozin，患有2型糖尿病的患者与二甲双胍单疗法不充分控制：52周的持续时间-8随机对照试验
2. Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial [J] . Frias Juan P., Guja Cristian, Hardy Elise, The lancet. Diabetes & endocrinology. . 2016,第12期

机译：在二甲双胍单药治疗不能充分控制的2型糖尿病患者中，每周一次艾塞那肽加dapagliflozin与单独使用艾塞那肽或dapagliflozin相比（DURATION-8）：一项为期28周的多中心，双盲，3期，随机对照试验
3. Comparative evaluation of efficacy and safety of combination of metformin-vidagliptin versus metfromin-glimepiride in most frequently used doses in patients of type 2 diabetes mellitus with inadequately controlled metformin monotherapy-A randomised open label study [J] . Shallini Gupta, Vijay Khajuria, Vishal R Tandon, Perspectives in Clinical Research . 2015,第3期

机译：二甲双胍-维达列汀与二甲双胍-格列美脲合用在二甲双胍单药治疗控制不充分的2型糖尿病患者中最常用剂量的疗效和安全性比较评估
4. Controlled Release of Metformin Loaded Polyvinyl Alcohol (PVA) Microbubble/Nanoparticles Using Microfluidic Device for the Treatment of Type 2 Diabetes Mellitus [C] . Sumeyye Cesur, Muhammet Emin Cam, Fatih Serdar Sayin, International work-conference on bioinformatics and biomedical engineering . 2020

机译：使用微流体装置控制二甲双胍负载的聚乙烯醇（PVA）微泡/纳米颗粒的控释，用于治疗2型糖尿病
5. Metformin use and the incidence of colorectal and lung cancer in patients with type 2 diabetes mellitus [D] . Smiechowski, Brielan. 2012

机译：二甲双胍的使用与2型糖尿病患者大肠癌和肺癌的发生率
6. Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial [O] . Serge A. Jabbour, Juan P. Frías, Elise Hardy, 2018

机译：二甲双胍单药治疗不能完全控制的2型糖尿病患者艾塞那肽每周一次加艾达那列或每日一次与艾塞那肽或达格列净相比的安全性和有效性：DURATION-8随机对照试验52周的结果
7. PDB71 The Cost-Effectiveness OF Canagliflozin (Cana) Versus Dapagliflozin (Dapa) In Patients With Type 2 Diabetes Mellitus (T2dm) With Inadequate Control On Metformin (Met) Monotherapy In The United Kingdom [O] . Schroeder M., Johansen P., Thompson G., 2014

机译：PDB71 Canagliflozin（Cana）与Dapagliflozin（Dapa）在2型糖尿病（T2dm）患者中对二甲双胍（Met）单药治疗控制不充分的成本效果

PDB50 The Cost-Effectiveness Evaluation of Canagliflozin Versus Dapagliflozin In Patients with type 2 Diabetes Mellitus Inadequately Controlled On Metformin Monotherapy In Spain

著录项

引文网络

相似文献

相关主题

期刊订阅